GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Chemed CHE · USD

Health Care · US listing · 🇺🇸 United States

Compare

538.06

+1.90%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$2.53bn

FY2016FY2025

Net income

$265.2m

FY2016FY2025

Free cash flow

$325.5m

FY2016FY2025

Shareholders' equity

$979.4m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$2.53bn$2.43bn$2.26bn$2.13bn$2.14bn$2.08bn$1.94bn$1.78bn$1.67bn$1.58bn
Gross profit$758.3m$854.3m$798.8m$765.1m$769.8m$701.4m$617.4m$555.0m$516.2m$461.4m
Operating income$338.2m$366.5m$342.0m$343.5m$344.5m$391.3m$261.4m$243.6m$121.2m$178.7m
Net income$265.2m$302.0m$272.5m$249.6m$268.6m$319.5m$219.9m$205.5m$98.2m$108.7m
Diluted earnings per share18.9520.1417.8516.5817.3119.5413.2812.335.856.55

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$1.64bn$1.67bn$1.67bn$1.44bn$1.34bn$1.43bn$1.27bn$975.5m$920.0m$880.1m
Cash and short-term investments$74.5m$178.3m$264.0m$74.1m$32.9m$162.7m$6.2m$4.8m$11.1m$15.3m
Total liabilities$660.6m$549.6m$560.2m$643.3m$719.5m$533.7m$541.7m$384.2m$379.7m$356.0m
Debt$51.9m—$15.7m$97.5m$196.9m—$99.8m$103.0m$116.5m$108.8m
Shareholders' equity$979.4m$1.12bn$1.11bn$798.7m$623.3m$901.2m$726.6m$591.3m$540.4m$524.1m
Shares outstanding14m15m15m15m16m16m17m17m17m17m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$388.3m$417.5m$330.3m$309.9m$308.6m$489.3m$301.2m$287.1m$162.5m$135.4m
Capital spending−$62.8m−$49.5m−$56.9m−$57.3m−$58.7m−$58.8m−$53.0m−$52.9m−$64.3m−$39.8m
Free cash flow$325.5m$368.0m$273.4m$252.6m$249.9m$430.5m$248.2m$234.3m$98.2m$95.6m
Dividends paid−$31.7m−$27.1m−$23.5m−$22.0m−$22.0m−$21.1m−$19.8m−$18.7m−$17.4m−$16.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$673.3m$657.5m$639.3m$624.9m$618.8m$646.9m$640.0m$606.2m
Gross profit$204.4m$198.9m$206.0m$180.7m$184.7m$216.4m$234.1m$210.0m
Operating income$89.2m$84.6m$100.7m$74.8m$68.1m$94.8m$113.9m$92.2m
Net income$67.7m$66.3m$76.8m$64.2m$52.5m$71.8m$90.3m$75.8m
Diluted earnings per share5.044.945.484.593.755.136.025.05
Cash from operations$84.0m$88.0m$133.0m$83.0m$138.0m$32.0m$164.0m$90.0m
Capital spending−$15.0m−$17.0m−$16.0m−$17.0m−$15.0m−$13.0m−$12.0m−$13.0m
Free cash flow$69.0m$71.0m$117.0m$66.0m$123.0m$19.0m$152.0m$77.0m
Total assets$1.58bn$1.54bn$1.64bn$1.62bn$1.72bn$1.73bn$1.67bn$1.77bn
Cash and short-term investments$40.2m$16.9m$74.5m$129.8m$249.9m$173.9m$178.3m$238.5m
Debt$41.3m$132.5m$51.9m$42.0m$43.7m$43.0m$42.3m$42.5m
Shareholders' equity$830.5m$848.0m$979.4m$1.08bn$1.20bn$1.18bn$1.12bn$1.24bn

Financial ratios

Data as of 11 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin30.0%35.1%35.3%35.8%36.0%33.7%
Operating margin14.1%16.5%15.6%15.7%16.5%19.2%
Net margin10.5%12.4%12.0%11.7%12.6%15.4%
Return on equity27.1%27.0%24.6%31.3%43.1%35.4%
Return on assets16.2%18.1%16.3%17.3%20.0%22.3%
Free cash flow yield6.4%6.2%5.1%4.9%4.7%6.7%
Revenue growth4.1%7.4%6.1%-0.2%2.9%7.3%
Earnings growth-12.2%10.8%9.2%-7.0%-15.9%45.3%
Current ratio1.05x1.38x1.61x0.92x0.76x1.10x
Debt to equity0.05x0.04x0.05x0.17x0.36x0.04x
Equity ratio59.7%67.1%66.4%55.4%46.4%62.8%
Interest coverage204.30x225.42x113.73x72.92x188.53x169.15x
Buybacks as a share of market value6.7%1.8%-1.4%3.0%5.1%1.3%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue5.8%4.0%5.1%
Operating income-0.5%-2.9%6.3%
Net income2.0%-3.7%9.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin32.5%33.9%34.2%32.8%
Operating margin14.2%14.9%15.7%14.1%
Net margin11.4%11.6%12.4%11.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings22.626.332.830.830.627.333.123.041.524.5
Price to sales2.43.33.93.63.84.23.82.62.51.7

Market value over time

30 Nov 2016 to 9 Oct 2026, in USD

$2.53bn$6.71bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-17%-12%17%-1%-3%20%63%11%50%10%

Dividends and splits

Per share, in the currency the company pays

Paid for 36 years. Last went ex-dividend on 17 Aug 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year1.902.201.801.561.481.401.321.24
  • 2-for-1 split · 12 May 2005

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.